Two research papers published this month identify possible molecular causes of the degenerative illness called cachexia that researchers hope could lead to potential treatments. Bruce Spiegelman, the Stanley J. Korsmeyer Professor of Cell Biology and Medicine at the Dana-Farber Cancer Institute, led one of the studies. Alfred L. Goldberg, professor of cell biology; Barrett J. Rollins, the Linde Family Professor of Medicine at the Dana-Farber Cancer Institute; Don S. Dizon, instructor in medicine at Massachusetts General Hospital; and Janet Abrahm, professor of medicine at the Dana-Farber Cancer Institute, are also quoted.
Stay informed via email on the latest news, research, and
media from Harvard Medical School.